Literature DB >> 2388972

Effects of repeated injection of sublethal doses of soman on behavior and on brain acetylcholine and choline concentrations in the rat.

T M Shih1, D E Lenz, D M Maxwell.   

Abstract

The effects of repeated exposure to a sublethal dose (60 micrograms/kg; 0.4 LD50) of soman on brain regional acetylcholine (ACh) and choline (Ch) levels, spinal cord cholinesterase (ChE) activity and on water consumption, body weight and gross behavioral changes were examined. Male rats were dosed once a week or three times a week and at 24 h after 2, 4 or 6 weeks of dosing, selected brain tissues and behavior were examined. During the 6-week period, there was no difference between control and soman-dosed rats in water consumption or body weight under either treatment regimen. The animals treated once a week adapted to this exposure regimen well. They exhibited no change in the levels of ACh or Ch in any of the brain areas when examined at the end of 2, 4 or 6 weeks, nor did they show any obvious signs of poisoning. The total ChE activity fluctuated between 70 and 100% of control. When treated three times a week, however, survivors (90%) of the soman-treated rats developed signs that progressed in severity to a hyper-reactivity syndrome which consisted of an exaggerated reaction to mild tactile stimuli. Brain ACh levels did not change and ChE activity showed inhibition of 40, 58 and 75% when measured at 2, 4 and 6 weeks, respectively. At the end of 6 weeks, the levels of Ch, except in the striatum, were significantly elevated in brainstem, cerebral cortex, hippocampus, midbrain, and cerebellum (52%, 147%, 68%, 46%, and 91%, respectively), indicating that Ch metabolism in neuronal membranes may be altered following more frequent low-dose soman exposures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388972     DOI: 10.1007/bf02244227

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  Studies on the toxicity and mechanism of action of p-nitrophenyl diethyl thionophosphate.

Authors:  K P DuBOIS; J DOULL
Journal:  J Pharmacol Exp Ther       Date:  1949-01       Impact factor: 4.030

2.  Effects of di-isopropylfluorophosphate on the metabolism of choline and phosphatidylcholine in rat brain.

Authors:  K Dross
Journal:  J Neurochem       Date:  1975-04       Impact factor: 5.372

3.  [Concentration of acetylcholine, choline and glycerylphosphorylcholine in the brain during anesthesia and in DFP poisoning].

Authors:  K Dross; H Kewitz
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate.

Authors:  J H Fleisher; L W Harris
Journal:  Biochem Pharmacol       Date:  1965-05       Impact factor: 5.858

5.  Activation of muscarinic receptors stimulates the release of choline from brain slices.

Authors:  V Dolezal; S Tucek
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

6.  Altered [3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorophosphate.

Authors:  F J Ehlert; N Kokka; A S Fairhurst
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

7.  Dealkylation studies on inhibited acetylcholinesterase.

Authors:  D B Coult; D J Marsh; G Read
Journal:  Biochem J       Date:  1966-03       Impact factor: 3.857

8.  Mobilization of cellular choline by stimulation of muscarine receptors in isolated chicken heart and rat cortex in vivo.

Authors:  R Corradetti; R Lindmar; K Löffelholz
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

9.  Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulphonyfluoride.

Authors:  R A Andersen; I Aaraas; G Gaare; F Fonnum
Journal:  Gen Pharmacol       Date:  1977
  9 in total
  1 in total

1.  Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats.

Authors:  Lucille A Lumley; Brenda Marrero-Rosado; Franco Rossetti; Caroline R Schultz; Michael F Stone; Jerome Niquet; Claude G Wasterlain
Journal:  Epilepsia Open       Date:  2021-10-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.